Open AccessImpact of real-time, dose-escalated permanent seed implant brachytherapy in intermediate-risk prostate cancer
Author(s) -
Olga Pons-Llanas,
E. Collado-Ballesteros,
S. Roldán-Ortega,
Antonio J. Conde-Moreno,
Francisco Javier Celada-Alvarez,
F J Martinez-Arcelus,
M.J. Pérez-Calatayud,
V. Carmona-Meseguer,
J. Gimeno-Olmos,
V. Forner-Ferrer,
Alejandro Tormo-Micó,
J. Pérez-Calatayud,
J. López-Torrecilla
Publication year - 2020
Publication title -
reports of practical oncology and radiotherapy
Language(s) - English
Resource type - Journals
eISSN - 2083-4640
pISSN - 1507-1367
DOI - 10.1016/j.rpor.2020.04.014
Subject(s) - medicine , prostate cancer , toxicity , brachytherapy , genitourinary system , urology , urethra , population , prostate , surgery , radiation therapy , cancer , environmental health
To retrospectively evaluate biochemical control and toxicity in patients who underwent 125I seed brachytherapy (BT) for intermediate-risk prostate cancer (PCa).